CN105326939A - Traditional Chinese medicine for treating heart and cerebral vusculer diseases - Google Patents
Traditional Chinese medicine for treating heart and cerebral vusculer diseases Download PDFInfo
- Publication number
- CN105326939A CN105326939A CN201510871232.9A CN201510871232A CN105326939A CN 105326939 A CN105326939 A CN 105326939A CN 201510871232 A CN201510871232 A CN 201510871232A CN 105326939 A CN105326939 A CN 105326939A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cardiovascular
- cerebrovascular disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 201000010099 disease Diseases 0.000 title abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 7
- 230000002490 cerebral effect Effects 0.000 title abstract 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 28
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 28
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 28
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 22
- 241000180649 Panax notoginseng Species 0.000 claims description 22
- 241001489978 Eupolyphaga Species 0.000 claims description 20
- 241000237903 Hirudo Species 0.000 claims description 20
- 241000972155 Moschus Species 0.000 claims description 20
- 241000237636 Pheretima Species 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003390 Chinese drug Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000003213 activating effect Effects 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 235000003365 Ilex pubescens Nutrition 0.000 abstract 1
- 241001100932 Ilex pubescens Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000002994 raw material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine for treating heart and cerebral vusculer diseases. The traditional Chinese medicine for treating heart and cerebral vusculer diseases is prepared from, by weight, 18-36 parts of the root of red-rooted salvia, 9-17 parts of the rhizome of chuanxiong, 12-24 parts of milkvetch roots, 15-20 parts of peach kernels, 15-20 parts of lumbricus, 10-20 parts of hawthorn fruits, 15-20 parts of musk, 10-20 parts of leech, 6-12 parts of ground beeltle, 20-30 parts of pubescent holly roots and 10-20 parts of pseudo-ginseng. The medicinal materials are matched, bring out the best in one another and achieve the effects of tonifying Qi, activating blood, removing blood stasis and clearing and activating the channels and collaterals, and the traditional Chinese medicine is widely used for treating heart and cerebral vusculer diseases.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof.
Background technology
At present, cardiovascular and cerebrovascular disease is the disease that a kind of disability rate is high.Once this kind of disease must be gone up, oneself be difficult to take care of oneself, cause very large financial burden and mental pressure to family.Patient oneself is also usually because tied down household, and mood is not smooth, have impact on the treatment of disease on the contrary.For cardiovascular and cerebrovascular disease, be no matter economically, family's angle, or from health perspectives, have prevention only and be only completely safe plan, brilliant act.Prevention in early one day, earlier feels at ease.The Chinese medicinal formulae of middle treatment cardiovascular and cerebrovascular disease, recipe drug is processed at one tens taste raw material of Chinese medicine, and prescription is large, and compatibility amount is complicated, and cost is high, has side effects many, gives the problem that patient brings financial burden overweight.
Summary of the invention
Object of the present invention, is to provide a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, it be Chinese medicine primarily of Radix Salviae Miltiorrhizae, Radix Notoginseng, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Pheretima, Fructus Crataegi, Moschus, Hirudo, Eupolyphaga Seu Steleophaga, Radix Ilicis Pubescentis, Radix Notoginseng raw material of Chinese medicine is through extraction, micronization, and processing and refining forms.
A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, be made up of following component by weight: Radix Salviae Miltiorrhizae 18-36 part, Rhizoma Chuanxiong 9-17 part, Radix Astragali 12-24 part, Semen Persicae 15-20 part, Pheretima 15-20 part, Fructus Crataegi 10-20 part, Moschus 15-20 part, Hirudo 10-20 part, Eupolyphaga Seu Steleophaga 6-12 part, Radix Ilicis Pubescentis 20-30 part, Radix Notoginseng 10-20 part.
The Chinese medicine of described treatment cardiovascular and cerebrovascular disease, be made up of following component by weight: Radix Salviae Miltiorrhizae 25-30 part, Rhizoma Chuanxiong 11-15 part, Radix Astragali 15-20 part, Semen Persicae 17-19 part, Pheretima 17-19 part, Fructus Crataegi 13-17 part, Moschus 17-19 part, Hirudo 13-17 part, Eupolyphaga Seu Steleophaga 7-11 part, Radix Ilicis Pubescentis 23-27 part, Radix Notoginseng 13-17 part.
The Chinese medicine of described treatment cardiovascular and cerebrovascular disease, is made up of following component by weight: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 13 parts, the Radix Astragali 17 parts, 18 parts, Semen Persicae, Pheretima 18 parts, Fructus Crataegi 15 parts, 18 parts, Moschus, Hirudo 15 parts, Eupolyphaga Seu Steleophaga 9 parts, Radix Ilicis Pubescentis 25 parts, Radix Notoginseng 15 parts.
Described form of Chinese drug is capsule; Granule or tablet.
Treat a Chinese medicinal preparation method for cardiovascular and cerebrovascular disease, concrete steps are: (1) prepares burden by above-mentioned weight portion;
(2) by Radix Notoginseng grinds, sieve for subsequent use;
(3) by Moschus grinds, sieve for subsequent use;
(3) by Eupolyphaga Seu Steleophaga, Pheretima, Hirudo mixes, grinds, sieves for subsequent use;
(4) by remaining Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Fructus Crataegi, Radix Ilicis Pubescentis steeps 0.5-1 in water individual hour, and then half an hour is endured out in big fire; Filter; Medicinal residues after filtering are continued to add water, endure 1 hour, after twice filtrate is merged; Add Eupolyphaga Seu Steleophaga successively, Rhizoma Chuanxiong, the powder of Hirudo mixing polishing; Add Moschus powder again; Finally put into Radix Notoginseng powder; Mix homogeneously, to obtain final product.
Add appropriate pharmaceutic adjuvant tabletted and namely obtain tablet, or add appropriate pharmaceutic adjuvant and make granule and namely obtain granule.
The main Prescription Effect of Chinese medicine: Radix Notoginseng: sweet, the micro-hardship of nature and flavor, temperature, returns liver, stomach warp, the hemostasis of function dissipating blood stasis, subduing swelling and relieving pain; Radix Salviae Miltiorrhizae: nature and flavor are bitter, be slightly cold, GUIXIN, Liver Channel, function stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness; Hirudo: nature and flavor are salty, bitter, flat, returns Liver Channel, function removing blood stasis, removing blood stasis, stimulates the menstrual flow; Eupolyphaga Seu Steleophaga: nature and flavor are salty, cold, return Liver Channel, function removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; Pheretima: Pheretima is cold in nature, salty in the mouth.Function: heat clearing away, suppressing the hyperactive liver, Zhichuan, dredging collateral.Return liver, stomach, lung, urinary bladder channel.Function heat clearing away suppressing the hyperactive liver, relieving spasm by subduing liver-wind, relieving asthma, diuresis, dredging collateral eliminating impediment; Semen Persicae sugariness is bitter, enters lung, flat, liver, large intestine channel; There is blood stasis removing and clots absorbing, moisturize effect of laxation; Control amenorrhea, dysmenorrhea, abdominal mass abdominal mass mass in the abdomen, traumatic injury, dryness of the intestine constipation; Moschus acrid in the mouth, warm in nature; GUIXIN, liver, spleen channel; Fragrant strongly alter loose, can rise and can fall, there is refreshment of having one's ideas straightened out, blood circulation promoting and dispersing pathogen accumulation, alleviating pain and detumescence, expedite the emergence of effect of lower tire; Above-mentioned drug matching, brings out the best in each other, and gathers effect of Yiqi-Huoxue-Huayu the meridian dredging altogether.
The invention has the beneficial effects as follows: Chinese medicine is primarily of Radix Salviae Miltiorrhizae, Radix Notoginseng, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, and Pheretima, Fructus Crataegi, Moschus, Hirudo, Eupolyphaga Seu Steleophaga, Radix Ilicis Pubescentis, Radix Notoginseng raw material of Chinese medicine is through extraction, micronization, and processing and refining forms.Its dosage form comprises capsule, tablet, granule.All medicines match, and bring out the best in each other, and gather effect of Yiqi-Huoxue-Huayu the meridian dredging altogether, and for the treatment of cardiovascular and cerebrovascular disease, have significant effect, total effective rate reaches 97.73%.
model case:
Zhao so-and-so, occupation: teacher; Threescore, has the household heredity factors of cardiovascular and cerebrovascular disease: symptom: emergent breast left part pain time tired or nervous, emits to shoulder, arm or cervical region with perspiration or pain; Feel during sleep to feel suffocated, just take a turn for the better after needing high pillow; Repeatedly occur that pulse is uneven, bradycardia; Than others easier chest distress and palpitation symptoms and with hypomnesis time upstairs.Have dizziness, slowness of thinking, general weakness, nervous, bradykinesia, behavior be inmature, etc. symptom; Take medicine after the course for the treatment of, sensation is significantly improved:
dizzy situation disappears, and left chest pain disappears, and speed aroused in interest is delayed normally by crossing.
" according to GCP " and " new Chinese medicine guideline of clinical investigations ", Chinese medicine of the present invention has carried out the clinical research for the treatment of cardiovascular and cerebrovascular disease.Data and method: Chinese drug-treated group 132 of the present invention example, wherein man 62 example, female 60 example, age 46-65 year, 53 years old mean age, stadium 6 months to 10 years.With three Zhou Weiyi the course for the treatment of, be used in conjunction two courses for the treatment of, follow up a case by regular visits to 3 months.Found that: treatment by Chinese herbs group 132 of the present invention example, clinical recovery 105 example, effective 13 examples, effective 11 examples, always effective 97.73%.Conclusion, Chinese medicine of the present invention has significant curative effect to cardiovascular and cerebrovascular disease.
Detailed description of the invention:
embodiment 1
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 18 parts, Rhizoma Chuanxiong 9 parts, the Radix Astragali 12 parts, 15 parts, Semen Persicae, Pheretima 15 parts, Fructus Crataegi 10 parts, 15 parts, Moschus, Hirudo 10 parts, Eupolyphaga Seu Steleophaga 6 parts, Radix Ilicis Pubescentis 20 parts, Radix Notoginseng 10 parts.
Its preparation technology is:
Treat a Chinese medicinal preparation method for cardiovascular and cerebrovascular disease, concrete steps are: (1) prepares burden by above-mentioned weight portion;
(2) by Radix Notoginseng grinds, sieve for subsequent use;
(3) by Moschus grinds, sieve for subsequent use;
(3) by Eupolyphaga Seu Steleophaga, Pheretima, Hirudo mixes, grinds, sieves for subsequent use;
(4) by remaining Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Fructus Crataegi, Radix Ilicis Pubescentis steeps 0.5-1 in water individual hour, and then half an hour is endured out in big fire; Filter; Medicinal residues after filtering are continued to add water, endure 1 hour, after twice filtrate is merged; Add Eupolyphaga Seu Steleophaga successively, Rhizoma Chuanxiong, the powder of Hirudo mixing polishing; Add Moschus powder again; Finally put into Radix Notoginseng powder; Mix homogeneously, to obtain final product.
Add appropriate pharmaceutic adjuvant tabletted and namely obtain tablet, or add appropriate pharmaceutic adjuvant and make granule and namely obtain granule.
embodiment 2
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 136 parts, Rhizoma Chuanxiong 17 parts, the Radix Astragali 24 parts, 20 parts, Semen Persicae, Pheretima 20 parts, Fructus Crataegi 20 parts, 20 parts, Moschus, Hirudo 20 parts, Eupolyphaga Seu Steleophaga 12 parts, Radix Ilicis Pubescentis 30 parts, Radix Notoginseng 20 parts.
Preparation technology is with embodiment 1.
embodiment 3
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 25 parts, Rhizoma Chuanxiong 11 parts, the Radix Astragali 15 parts, 17 parts, Semen Persicae, Pheretima 17 parts, Fructus Crataegi 13 parts, 17 parts, Moschus, Hirudo 13 parts, Eupolyphaga Seu Steleophaga 7 parts, Radix Ilicis Pubescentis 23 parts, Radix Notoginseng 13 parts.
Preparation technology is with embodiment 1.
embodiment 4
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 30 parts, Rhizoma Chuanxiong 15 parts, the Radix Astragali 20 parts, 19 parts, Semen Persicae, Pheretima 19 parts, Fructus Crataegi 17 parts, 19 parts, Moschus, Hirudo 17 parts, Eupolyphaga Seu Steleophaga 11 parts, Radix Ilicis Pubescentis 27 parts, Radix Notoginseng 17 parts.
Preparation technology is with embodiment 1.
embodiment 5
The Chinese medicine for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 1, it is made up of following component by weight: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 13 parts, the Radix Astragali 17 parts, 18 parts, Semen Persicae, Pheretima 18 parts, Fructus Crataegi 15 parts, 18 parts, Moschus, Hirudo 15 parts, Eupolyphaga Seu Steleophaga 9 parts, Radix Ilicis Pubescentis 25 parts, Radix Notoginseng 15 parts.
Preparation technology is with embodiment 1.
Claims (8)
1. treat the Chinese medicine of cardiovascular and cerebrovascular disease for one kind, it is characterized in that: be made up of following component by weight: Radix Salviae Miltiorrhizae 18-36 part, Rhizoma Chuanxiong 9-17 part, Radix Astragali 12-24 part, Semen Persicae 15-20 part, Pheretima 15-20 part, Fructus Crataegi 10-20 part, Moschus 15-20 part, Hirudo 10-20 part, Eupolyphaga Seu Steleophaga 6-12 part, Radix Ilicis Pubescentis 20-30 part, Radix Notoginseng 10-20 part.
2. the Chinese medicine for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 1, it is characterized in that: be made up of following component by weight: Radix Salviae Miltiorrhizae 25-30 part, Rhizoma Chuanxiong 11-15 part, Radix Astragali 15-20 part, Semen Persicae 17-19 part, Pheretima 17-19 part, Fructus Crataegi 13-17 part, Moschus 17-19 part, Hirudo 13-17 part, Eupolyphaga Seu Steleophaga 7-11 part, Radix Ilicis Pubescentis 23-27 part, Radix Notoginseng 13-17 part.
3. the Chinese medicine for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 1, it is characterized in that: be made up of following component by weight: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 13 parts, the Radix Astragali 17 parts, 18 parts, Semen Persicae, Pheretima 18 parts, Fructus Crataegi 15 parts, 18 parts, Moschus, Hirudo 15 parts, Eupolyphaga Seu Steleophaga 9 parts, Radix Ilicis Pubescentis 25 parts, Radix Notoginseng 15 parts.
4. the Chinese medicine of the treatment cardiovascular and cerebrovascular disease as described in claim as arbitrary in claim 1-3, is characterized in that: described form of Chinese drug is capsule.
5. the Chinese medicine of the treatment cardiovascular and cerebrovascular disease as described in claim as arbitrary in claim 1-3, is characterized in that: described form of Chinese drug is granule.
6. the Chinese medicine of the treatment cardiovascular and cerebrovascular disease as described in claim as arbitrary in claim 1-3, is characterized in that: described form of Chinese drug is tablet.
7. a kind of Chinese medicinal preparation method for the treatment of cardiovascular and cerebrovascular disease according to claim 1, is characterized in that: concrete steps are: (1) prepares burden by above-mentioned weight portion;
(2) by Radix Notoginseng grinds, sieve for subsequent use;
(3) by Moschus grinds, sieve for subsequent use;
(3) by Eupolyphaga Seu Steleophaga, Pheretima, Hirudo mixes, grinds, sieves for subsequent use;
(4) by remaining Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Fructus Crataegi, Radix Ilicis Pubescentis steeps 0.5-1 in water individual hour, and then half an hour is endured out in big fire; Filter; Medicinal residues after filtering are continued to add water, endure 1 hour, after twice filtrate is merged; Add Eupolyphaga Seu Steleophaga successively, Rhizoma Chuanxiong, the powder of Hirudo mixing polishing; Add Moschus powder again; Finally put into Radix Notoginseng powder; Mix homogeneously, to obtain final product.
8. a kind of Chinese medicinal preparation method for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 7, is characterized in that: add appropriate pharmaceutic adjuvant tabletted and namely obtain tablet, or adds appropriate pharmaceutic adjuvant and make granule and namely obtain granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510871232.9A CN105326939A (en) | 2015-12-02 | 2015-12-02 | Traditional Chinese medicine for treating heart and cerebral vusculer diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510871232.9A CN105326939A (en) | 2015-12-02 | 2015-12-02 | Traditional Chinese medicine for treating heart and cerebral vusculer diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105326939A true CN105326939A (en) | 2016-02-17 |
Family
ID=55277845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510871232.9A Withdrawn CN105326939A (en) | 2015-12-02 | 2015-12-02 | Traditional Chinese medicine for treating heart and cerebral vusculer diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105326939A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920375A (en) * | 2016-07-06 | 2016-09-07 | 贾庭山 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
| CN106938048A (en) * | 2017-04-11 | 2017-07-11 | 王敬顺 | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
| CN107375562A (en) * | 2017-08-09 | 2017-11-24 | 裴然 | A kind of Chinese medicine and boiling method of effectively treatment cardiovascular and cerebrovascular disease |
-
2015
- 2015-12-02 CN CN201510871232.9A patent/CN105326939A/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| 黎利芬等: "黄芪活血汤治疗脑梗死急性期158例疗效观察", 《中国中医急症》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920375A (en) * | 2016-07-06 | 2016-09-07 | 贾庭山 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
| CN106938048A (en) * | 2017-04-11 | 2017-07-11 | 王敬顺 | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
| CN107375562A (en) * | 2017-08-09 | 2017-11-24 | 裴然 | A kind of Chinese medicine and boiling method of effectively treatment cardiovascular and cerebrovascular disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN103566236A (en) | Traditional Chinese medicinal preparation for dispelling dampness and soothing channel | |
| CN103432390A (en) | Medicament for treating coronary heart disease and preparation method thereof | |
| CN103977217A (en) | Medicinal composition for treating renal carcinoma | |
| CN103463607A (en) | Preparation method for medicament for treating postpartum disease | |
| CN105326939A (en) | Traditional Chinese medicine for treating heart and cerebral vusculer diseases | |
| CN104491236A (en) | Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation | |
| CN104398980A (en) | Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method of traditional Chinese medicine preparation | |
| CN103830436A (en) | Traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN104225275A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN103285128B (en) | Traditional Chinese medicine for treating bronchial asthma and preparation method thereof | |
| CN102366469A (en) | Drug for treating leucoderma | |
| CN105327157A (en) | Traditional Chinese medicine for treating cerebrovascular blockage and preparation method thereof | |
| CN105327003A (en) | Traditional Chinese medicine for treating cardiovascular diseases and preparation method thereof | |
| CN105326949A (en) | Traditional Chinese medicine for treating cardiovascular blockage and preparation method thereof | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN103156979B (en) | A kind of dispelling speckles and whitening face medicine | |
| CN102743499A (en) | Chinese medicinal herb drug for treating soft tissue internal injury blood stasis and cerebral hemorrhage | |
| CN103520352A (en) | Traditional Chinese medicine for treating venation stasis and obstruction symptom type chest stuffiness and pains | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN102366510A (en) | Traditional Chinese medicine for treating hypercortisolism | |
| CN105535817A (en) | A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof | |
| CN105456743A (en) | Chinese medicine for treating cerebrovascular disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160217 |
|
| WW01 | Invention patent application withdrawn after publication |